Analysis of the Squamous Cell Carcinoma Antigen (SCCA) Which Has a Significant Difference in Values between CLIA and FEIA--Case Report of Extra Glycosylation in SCCA

Kanae Maruyama, Yoshimasa Aoki, Motoko Yamanaka, Miyuki Ono, Taeko Hotta, Dongchon Kang

Research output: Contribution to journalArticle

Abstract

Squamous cell carcinoma antigen (SCCA) is a glycoprotein that belongs to the serine protease inhibitor family. Clinically, it has been utilized as a tumor marker for squamous cell carcinoma. In clinical laboratories, SCCA is measured by several immunoassays. Recently, a number of studies have been reported that there is a significant difference in values between the immunoassays, attributing to SCCA-immunoglobulin complex. We found a case with significant difference in the SCCA value between CLIA and FEIA. In this case, SCCA-Immunoglobulin complex was not confirmed by gel filtration analysis. Interestingly, 5 to 10 kDa slightly-high molecular weight SCCA compared to control was detected by immunoblotting assay. It may be suspected that the aberrant glycosyl modification of SCCA influenced the reactivity to immunoassays.

Original languageEnglish
Pages (from-to)265-269
Number of pages5
JournalRinsho byori. The Japanese journal of clinical pathology
Volume64
Issue number3
Publication statusPublished - Mar 1 2016

Fingerprint

Glycosylation
Immunoassay
Immunoglobulins
Serine Proteinase Inhibitors
Tumor Biomarkers
squamous cell carcinoma-related antigen
Immunoblotting
Gel Chromatography
Squamous Cell Carcinoma
Glycoproteins
Molecular Weight

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Analysis of the Squamous Cell Carcinoma Antigen (SCCA) Which Has a Significant Difference in Values between CLIA and FEIA--Case Report of Extra Glycosylation in SCCA. / Maruyama, Kanae; Aoki, Yoshimasa; Yamanaka, Motoko; Ono, Miyuki; Hotta, Taeko; Kang, Dongchon.

In: Rinsho byori. The Japanese journal of clinical pathology, Vol. 64, No. 3, 01.03.2016, p. 265-269.

Research output: Contribution to journalArticle

@article{62b6a701625344c68535b3e45ce10b57,
title = "Analysis of the Squamous Cell Carcinoma Antigen (SCCA) Which Has a Significant Difference in Values between CLIA and FEIA--Case Report of Extra Glycosylation in SCCA",
abstract = "Squamous cell carcinoma antigen (SCCA) is a glycoprotein that belongs to the serine protease inhibitor family. Clinically, it has been utilized as a tumor marker for squamous cell carcinoma. In clinical laboratories, SCCA is measured by several immunoassays. Recently, a number of studies have been reported that there is a significant difference in values between the immunoassays, attributing to SCCA-immunoglobulin complex. We found a case with significant difference in the SCCA value between CLIA and FEIA. In this case, SCCA-Immunoglobulin complex was not confirmed by gel filtration analysis. Interestingly, 5 to 10 kDa slightly-high molecular weight SCCA compared to control was detected by immunoblotting assay. It may be suspected that the aberrant glycosyl modification of SCCA influenced the reactivity to immunoassays.",
author = "Kanae Maruyama and Yoshimasa Aoki and Motoko Yamanaka and Miyuki Ono and Taeko Hotta and Dongchon Kang",
year = "2016",
month = "3",
day = "1",
language = "English",
volume = "64",
pages = "265--269",
journal = "Rinsho byori. The Japanese journal of clinical pathology",
issn = "0047-1860",
publisher = "Nihon Rinsho Byori Gakkai",
number = "3",

}

TY - JOUR

T1 - Analysis of the Squamous Cell Carcinoma Antigen (SCCA) Which Has a Significant Difference in Values between CLIA and FEIA--Case Report of Extra Glycosylation in SCCA

AU - Maruyama, Kanae

AU - Aoki, Yoshimasa

AU - Yamanaka, Motoko

AU - Ono, Miyuki

AU - Hotta, Taeko

AU - Kang, Dongchon

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Squamous cell carcinoma antigen (SCCA) is a glycoprotein that belongs to the serine protease inhibitor family. Clinically, it has been utilized as a tumor marker for squamous cell carcinoma. In clinical laboratories, SCCA is measured by several immunoassays. Recently, a number of studies have been reported that there is a significant difference in values between the immunoassays, attributing to SCCA-immunoglobulin complex. We found a case with significant difference in the SCCA value between CLIA and FEIA. In this case, SCCA-Immunoglobulin complex was not confirmed by gel filtration analysis. Interestingly, 5 to 10 kDa slightly-high molecular weight SCCA compared to control was detected by immunoblotting assay. It may be suspected that the aberrant glycosyl modification of SCCA influenced the reactivity to immunoassays.

AB - Squamous cell carcinoma antigen (SCCA) is a glycoprotein that belongs to the serine protease inhibitor family. Clinically, it has been utilized as a tumor marker for squamous cell carcinoma. In clinical laboratories, SCCA is measured by several immunoassays. Recently, a number of studies have been reported that there is a significant difference in values between the immunoassays, attributing to SCCA-immunoglobulin complex. We found a case with significant difference in the SCCA value between CLIA and FEIA. In this case, SCCA-Immunoglobulin complex was not confirmed by gel filtration analysis. Interestingly, 5 to 10 kDa slightly-high molecular weight SCCA compared to control was detected by immunoblotting assay. It may be suspected that the aberrant glycosyl modification of SCCA influenced the reactivity to immunoassays.

UR - http://www.scopus.com/inward/record.url?scp=85021855775&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021855775&partnerID=8YFLogxK

M3 - Article

VL - 64

SP - 265

EP - 269

JO - Rinsho byori. The Japanese journal of clinical pathology

JF - Rinsho byori. The Japanese journal of clinical pathology

SN - 0047-1860

IS - 3

ER -